Medical Supply Platform Zoplar Nets $3.4 Mn Led By Blume Ventures
Zoplar has secured $3.4 Mn in a Series A funding round led by Blume Ventures, along with participation from other investors.
Related Articles
Health Care Workforce Challenges Persist as a Legacy of Covid-19
HEALTH CARE WORKFORCE INNOVATION THEME ISSUE: NEJM Catalyst Insights Council members worldwide say that staffing shortages and clinician burnout remain difficult.
Impact of Private Equity Acquisition on Patient Care Experience in US Hospitals
Private equity acquisitions of health care facilities have rapidly increased over the past decade. However, little is known about the effects of these acquisitions on…
Changes in Patient Care Experience After Private Equity Acquisition of US Hospitals
This cross-sectional study compares global patient measures to determine whether patients experienced a change in care and whether hospital communication, clinical process, and environment changed…
Outcomes After Close Collaboration With Parents Intervention in NICUs
This nonrandomized clinical trial evaluates whether an educational program for neonatal intensive care unit (NICU) staff on family-centered care is associated with parent and staff…
Dissociable roles of central striatum and anterior lateral motor area in initiating and sustaining naturalistic behavior
Corbit et al. studied patterns of activity in corticostriatal circuits during naturally occurring complex behavior in mice. In contrast to models in which cortex leads striatum,…
Welcome! You are invited to join a webinar: All About our Content Eligibility Guidelines. After registering, you will receive a confirmation email about joining the webinar.
Join us for this informative webinar that will cover the eligibility guidelines for submitting news releases and multimedia content on our platform. PIOs will learn…
Can Kappa and Alpha-2 Agonist Agents Treat Opioid-Induced Ventilatory Depression Risk While Preserving Analgesic Effects?
A team of Cleveland Clinic researchers is exploring new antidotes against fentanyl overdose that eliminate the respiratory depression effects of opioids without interfering with their…
New Phase 2a Findings Released on IMG-007 Treatment of Atopic Dermatitis
New topline data released by Inmagene indicate positive findings from a phase 2a trial on IMG-007 for moderate-to-severe atopic dermatitis.
S1E4: The You You Are
Podcast Episode · The Severance Podcast with Ben Stiller & Adam Scott · 01/09/2025 · 58m
Exclusive | Blackstone to Make $300 Million Investment in AI Data Company
DDN attracts a $300 million infusion from the private-equity firm.
